| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-198507000-00003 |
| P698 | PubMed publication ID | 3892220 |
| P2093 | author name string | J Moore | |
| J P Johnson | |||
| H A Austin | |||
| J E Balow | |||
| C B Wilson | |||
| T T Antonovych | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 219-227 | |
| P577 | publication date | 1985-07-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors | |
| P478 | volume | 64 |
| Q35671818 | 65-year-old woman with shortness of breath and dark urine |
| Q33534334 | A 12-year-old girl with pulmonary hemorrhage, skin lesions, and hematuria |
| Q68037761 | A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group |
| Q36861294 | Advances in apheresis therapy for glomerular diseases |
| Q37902502 | Advances in human antiglomerular basement membrane disease |
| Q41475173 | Alveolar hemorrhage in patients with rheumatic disease |
| Q35831193 | Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit |
| Q55508549 | Anti-Glomerular Basement Membrane Disease. |
| Q42137758 | Anti-basement membrane antibody disease with severe pulmonary haemorrhage and normal renal function |
| Q37130127 | Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan |
| Q45907655 | Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. |
| Q69056816 | Anti-glomerular basement membrane antibody-mediated glomerulonephritis due to glue sniffing |
| Q58214883 | Antiglomerular basement membrane autoantibodies are nonpathogenic in Wegener's granulomatosis |
| Q37820338 | Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach |
| Q35856096 | Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. |
| Q87393403 | Chapter 14: Anti-glomerular basement membrane antibody glomerulonephritis |
| Q30451700 | Clinical applications of therapeutic apheresis |
| Q68928729 | Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease |
| Q34021733 | Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis |
| Q41484969 | Diagnosis and management of glomerular diseases |
| Q37939577 | Diagnosis and management of glomerulonephritis and vasculitis presenting as acute renal failure |
| Q47156066 | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
| Q42378750 | Effectiveness of Plasmapheresis in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis with Advanced Kidney Dysfunction. |
| Q47845010 | Goodpasture's disease: Antiglomerular basement membrane disease |
| Q30469628 | Goodpasture's syndrome |
| Q35689907 | Immunomodulation effects and clinical evidence of apheresis in renal diseases |
| Q39675170 | Immunopathogenesis of crescentic glomerulonephritis and lung purpura |
| Q35199878 | Indications of plasma exchanges for systemic vasculitides |
| Q89634313 | Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014 |
| Q35232146 | Maternal, pregnancy and fetal outcomes in de novo anti-glomerular basement membrane antibody disease in pregnancy: a systematic review |
| Q42973858 | Nephrology, dialysis and transplantation |
| Q33749721 | Nonresolving or slowly resolving pneumonia |
| Q36306747 | Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience |
| Q33342767 | Plasmapheresis. Technical aspects and indications |
| Q37340194 | Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study |
| Q26830899 | Principles of separation: indications and therapeutic targets for plasma exchange |
| Q77903324 | Pulmonary manifestations of Goodpasture's syndrome. Antiglomerular basement membrane disease and related disorders |
| Q34990088 | Pulmonary-renal syndromes in the intensive care unit |
| Q92704421 | Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy |
| Q39644050 | Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy |
| Q79181944 | Rapidly progressive glomerulonephritis:classification, pathogenesis and clinical management |
| Q57945954 | References |
| Q35310890 | Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy |
| Q33595424 | Role of bronchoscopy in massive hemoptysis |
| Q101563279 | Role of therapeutic plasma exchanges in systemic vasculitis |
| Q90114388 | Severe Infection in Anti-Glomerular Basement Membrane Disease: A Retrospective Multicenter French Study |
| Q40698546 | The approach to nonresolving pneumonia. |
| Q36053839 | The role of plasmapheresis in critical illness |
| Q87954665 | The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis |
| Q39484864 | The treatment of immune glomerular disease |
| Q35199884 | The use of apheresis in immune renal disorders |
| Q64260727 | Therapeutic Plasma Exchange in Renal Disorders |
| Q38118112 | Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. |
| Q91566737 | Therapeutic plasma exchange in nephrology. Where it applies? |
| Q36280174 | Unresolved issues and current concepts in management of primary glomerulonephritis. |
| Q58711212 | Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease |
| Q93111593 | [What are the indications for rescue procedures? : Systemic rheumatic diseases in the intensive care unit] |
Search more.